+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LDL-C Lowering Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 107 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5729375
Description Jump to:

Quick Summary:

In the continually evolving landscape of the global LDL-C Lowering Therapeutics market, staying updated on industry trends, player profiles, and regional dynamics becomes more valuable than ever. Our comprehensive report provides in-depth, strategic insights that enable businesses to make calculated decisions, optimize resources, and maximize growth.

With a detailed geographical breakdown covering regions like North America, Europe, Asia & Pacific, South America, and MEA, it offers a holistic view of the sector, along with information on key local markets. Its coverage spans from reputable players to emergent ones, delivering valuable competitive intelligence. Each player's data includes a comprehensive company profile, SWOT analysis, business information, and critical financial metrics securing an edge in this competitive landscape. Not only does it delve into a detailed categorization of product types, such as statins, ezetimibe, and lomitapide among others, but also offers market size forecasts that lead the businesses of today into the growth of tomorrow.

This report describes the global market size of LDL-C Lowering Therapeutics from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of LDL-C Lowering Therapeutics as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment

  • statins
  • ezetimibe
  • bempedoic acid
  • lomitapide
  • mipomersen and icosapent ethyl
  • Others

Companies Covered

  • Amgen
  • Sanofi/Regeneron Pharmaceuticals
  • Novartis
  • Serometrix LLC
  • Verve Therapeutics
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Ldl-C Lowering Therapeutics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Ldl-C Lowering Therapeutics Market in North America (2019-2029)
8.1 Ldl-C Lowering Therapeutics Market Size
8.2 Ldl-C Lowering Therapeutics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Ldl-C Lowering Therapeutics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Ldl-C Lowering Therapeutics Market in South America (2019-2029)
9.1 Ldl-C Lowering Therapeutics Market Size
9.2 Ldl-C Lowering Therapeutics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Ldl-C Lowering Therapeutics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Ldl-C Lowering Therapeutics Market in Asia & Pacific (2019-2029)
10.1 Ldl-C Lowering Therapeutics Market Size
10.2 Ldl-C Lowering Therapeutics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Ldl-C Lowering Therapeutics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Ldl-C Lowering Therapeutics Market in Europe (2019-2029)
11.1 Ldl-C Lowering Therapeutics Market Size
11.2 Ldl-C Lowering Therapeutics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Ldl-C Lowering Therapeutics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Ldl-C Lowering Therapeutics Market in MEA (2019-2029)
12.1 Ldl-C Lowering Therapeutics Market Size
12.2 Ldl-C Lowering Therapeutics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Ldl-C Lowering Therapeutics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Ldl-C Lowering Therapeutics Market (2019-2024)
13.1 Ldl-C Lowering Therapeutics Market Size
13.2 Ldl-C Lowering Therapeutics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Ldl-C Lowering Therapeutics Market Size by Type
Chapter 14 Global Ldl-C Lowering Therapeutics Market Forecast (2024-2029)
14.1 Ldl-C Lowering Therapeutics Market Size Forecast
14.2 Ldl-C Lowering Therapeutics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Ldl-C Lowering Therapeutics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Amgen
15.1.1 Company Profile
15.1.2 Main Business and LDL-C Lowering Therapeutics Information
15.1.3 SWOT Analysis of Amgen
15.1.4 Amgen LDL-C Lowering Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.2 Sanofi/Regeneron Pharmaceuticals
15.2.1 Company Profile
15.2.2 Main Business and LDL-C Lowering Therapeutics Information
15.2.3 SWOT Analysis of Sanofi/Regeneron Pharmaceuticals
15.2.4 Sanofi/Regeneron Pharmaceuticals LDL-C Lowering Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.3 Novartis
15.3.1 Company Profile
15.3.2 Main Business and LDL-C Lowering Therapeutics Information
15.3.3 SWOT Analysis of Novartis
15.3.4 Novartis LDL-C Lowering Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.4 Serometrix LLC
15.4.1 Company Profile
15.4.2 Main Business and LDL-C Lowering Therapeutics Information
15.4.3 SWOT Analysis of Serometrix LLC
15.4.4 Serometrix LLC LDL-C Lowering Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
15.5 Verve Therapeutics
15.5.1 Company Profile
15.5.2 Main Business and LDL-C Lowering Therapeutics Information
15.5.3 SWOT Analysis of Verve Therapeutics
15.5.4 Verve Therapeutics LDL-C Lowering Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Ldl-C Lowering Therapeutics Report
Table Data Sources of Ldl-C Lowering Therapeutics Report
Table Major Assumptions of Ldl-C Lowering Therapeutics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Ldl-C Lowering Therapeutics Picture
Table Ldl-C Lowering Therapeutics Classification
Table Ldl-C Lowering Therapeutics Applications
Table Drivers of Ldl-C Lowering Therapeutics Market
Table Restraints of Ldl-C Lowering Therapeutics Market
Table Opportunities of Ldl-C Lowering Therapeutics Market
Table Threats of Ldl-C Lowering Therapeutics Market
Table COVID-19 Impact For Ldl-C Lowering Therapeutics Market
Table Raw Materials Suppliers
Table Different Production Methods of Ldl-C Lowering Therapeutics
Table Cost Structure Analysis of Ldl-C Lowering Therapeutics
Table Key End Users
Table Latest News of Ldl-C Lowering Therapeutics Market
Table Merger and Acquisition
Table Planned/Future Project of Ldl-C Lowering Therapeutics Market
Table Policy of Ldl-C Lowering Therapeutics Market
Table 2019-2029 North America Ldl-C Lowering Therapeutics Market Size
Figure 2019-2029 North America Ldl-C Lowering Therapeutics Market Size and CAGR
Table 2019-2029 North America Ldl-C Lowering Therapeutics Market Size by Application
Table 2019-2024 North America Ldl-C Lowering Therapeutics Key Players Revenue
Table 2019-2024 North America Ldl-C Lowering Therapeutics Key Players Market Share
Table 2019-2029 North America Ldl-C Lowering Therapeutics Market Size by Type
Table 2019-2029 United States Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Canada Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Mexico Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 South America Ldl-C Lowering Therapeutics Market Size
Figure 2019-2029 South America Ldl-C Lowering Therapeutics Market Size and CAGR
Table 2019-2029 South America Ldl-C Lowering Therapeutics Market Size by Application
Table 2019-2024 South America Ldl-C Lowering Therapeutics Key Players Revenue
Table 2019-2024 South America Ldl-C Lowering Therapeutics Key Players Market Share
Table 2019-2029 South America Ldl-C Lowering Therapeutics Market Size by Type
Table 2019-2029 Brazil Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Argentina Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Chile Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Peru Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Asia & Pacific Ldl-C Lowering Therapeutics Market Size
Figure 2019-2029 Asia & Pacific Ldl-C Lowering Therapeutics Market Size and CAGR
Table 2019-2029 Asia & Pacific Ldl-C Lowering Therapeutics Market Size by Application
Table 2019-2024 Asia & Pacific Ldl-C Lowering Therapeutics Key Players Revenue
Table 2019-2024 Asia & Pacific Ldl-C Lowering Therapeutics Key Players Market Share
Table 2019-2029 Asia & Pacific Ldl-C Lowering Therapeutics Market Size by Type
Table 2019-2029 China Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 India Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Japan Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 South Korea Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Southeast Asia Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Australia Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Europe Ldl-C Lowering Therapeutics Market Size
Figure 2019-2029 Europe Ldl-C Lowering Therapeutics Market Size and CAGR
Table 2019-2029 Europe Ldl-C Lowering Therapeutics Market Size by Application
Table 2019-2024 Europe Ldl-C Lowering Therapeutics Key Players Revenue
Table 2019-2024 Europe Ldl-C Lowering Therapeutics Key Players Market Share
Table 2019-2029 Europe Ldl-C Lowering Therapeutics Market Size by Type
Table 2019-2029 Germany Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 France Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 United Kingdom Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Italy Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Spain Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Belgium Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Netherlands Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Austria Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Poland Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Russia Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 MEA Ldl-C Lowering Therapeutics Market Size
Figure 2019-2029 MEA Ldl-C Lowering Therapeutics Market Size and CAGR
Table 2019-2029 MEA Ldl-C Lowering Therapeutics Market Size by Application
Table 2019-2024 MEA Ldl-C Lowering Therapeutics Key Players Revenue
Table 2019-2024 MEA Ldl-C Lowering Therapeutics Key Players Market Share
Table 2019-2029 MEA Ldl-C Lowering Therapeutics Market Size by Type
Table 2019-2029 Egypt Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Israel Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 South Africa Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Gulf Cooperation Council Countries Ldl-C Lowering Therapeutics Market Size
Table 2019-2029 Turkey Ldl-C Lowering Therapeutics Market Size
Table 2019-2024 Global Ldl-C Lowering Therapeutics Market Size by Region
Table 2019-2024 Global Ldl-C Lowering Therapeutics Market Size Share by Region
Table 2019-2024 Global Ldl-C Lowering Therapeutics Market Size by Application
Table 2019-2024 Global Ldl-C Lowering Therapeutics Market Share by Application
Table 2019-2024 Global Ldl-C Lowering Therapeutics Key Vendors Revenue
Figure 2019-2024 Global Ldl-C Lowering Therapeutics Market Size and Growth Rate
Table 2019-2024 Global Ldl-C Lowering Therapeutics Key Vendors Market Share
Table 2019-2024 Global Ldl-C Lowering Therapeutics Market Size by Type
Table 2019-2024 Global Ldl-C Lowering Therapeutics Market Share by Type
Table 2024-2029 Global Ldl-C Lowering Therapeutics Market Size by Region
Table 2024-2029 Global Ldl-C Lowering Therapeutics Market Size Share by Region
Table 2024-2029 Global Ldl-C Lowering Therapeutics Market Size by Application
Table 2024-2029 Global Ldl-C Lowering Therapeutics Market Share by Application
Table 2024-2029 Global Ldl-C Lowering Therapeutics Key Vendors Revenue
Figure 2024-2029 Global Ldl-C Lowering Therapeutics Market Size and Growth Rate
Table 2024-2029 Global Ldl-C Lowering Therapeutics Key Vendors Market Share
Table 2024-2029 Global Ldl-C Lowering Therapeutics Market Size by Type
Table 2024-2029 Ldl-C Lowering Therapeutics Global Market Share by Type

Companies Mentioned

  • Amgen
  • Sanofi/Regeneron Pharmaceuticals
  • Novartis
  • Serometrix LLC
  • Verve Therapeutics

Methodology

Loading
LOADING...

Related Topics

Related Reports

Familial Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Familial Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia - Pipeline Insight, 2024 - Product Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia - Pipeline Insight, 2024

  • Clinical Trials
  • 50 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Homozygous Familial Hypercholesterolemia Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Heterozygous Familial Hypercholesterolemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Heterozygous Familial Hypercholesterolemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 140 Pages
  • Global
From
Cholesterol Lowering Drug Market by Disease Type, Class of Drug, Distribution Channels - Global Forecast 2025-2030 - Product Image

Cholesterol Lowering Drug Market by Disease Type, Class of Drug, Distribution Channels - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.